Wealth Enhancement Advisory Services’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$264K Sell
10,576
-14,176
-57% -$332K ﹤0.01% 3327
2026
Q1
$345K Buy
24,752
+5,385
+28% +$72.6K ﹤0.01% 2637
2025
Q4
$227K Sell
19,367
-10,067
-34% -$115K ﹤0.01% 3166
2025
Q3
$333K Buy
29,434
+8,250
+39% +$96.6K ﹤0.01% 2695
2025
Q2
$262K Buy
+21,184
New +$266K ﹤0.01% 2748

Other funds holding AVNS

Wealth Enhancement Advisory Services's AVNS Position: Q2 2026 in Review

Wealth Enhancement Advisory Services reduced its Avanos Medical (AVNS) stake by 57% in Q2 2026, selling an estimated $332K and leaving 10,576 shares worth $264K. The position accounts for ﹤0.01% of the portfolio, ranked #3327.

Wealth Enhancement Advisory Services first reported a position in AVNS in Q2 2025 and has held it in 5 quarters since. The position peaked at $345K in Q1 2026. 74 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Wealth Enhancement Advisory Services held 10,576 shares of Avanos Medical worth $264K as of Q2 2026.
  • Wealth Enhancement Advisory Services sold 14,176 Avanos Medical shares in Q2 2026, an estimated $332K.
  • Avanos Medical made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3327 holding.
  • Wealth Enhancement Advisory Services first reported a position in Avanos Medical in Q2 2025 and has held it in 5 quarters since.
  • Wealth Enhancement Advisory Services's Avanos Medical position peaked at $345K in Q1 2026.
  • 74 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.